DeepMed Research

LEO LABORATORIES LIMITED

🇮🇪Ireland

Country: 🇮🇪Ireland

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis

Phase 3

Completed

Conditions: Psoriasis of Scalp

First Posted Date: 2005-09-22

Last Posted Date: 2025-02-24

Lead Sponsor: LEO Pharma

Target Recruit Count: 1350

Registration Number: NCT00216840

Locations: 🇩🇪
Georg-August-Universität Göttingen, Abteilung Dermatologie und Venerologie, Göttingen, Germany
🇬🇧
Royal Gwent Hospital, Department of Dermatology, Newport, United Kingdom
🇫🇮
Policlinic of Dermatology, Medical Reception Centre, Turku, Finland

and more 4 locations

Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris

Phase 4

Completed

Conditions: Psoriasis Vulgaris

First Posted Date: 2005-09-22

Last Posted Date: 2025-02-24

Lead Sponsor: LEO Pharma

Target Recruit Count: 1032

Registration Number: NCT00216892

Locations: 🇧🇪
Universitair Ziekenhuis, Gent, Belgium
🇨🇦
Dermatrials Research Dermatology Centre, Hamilton, Ontario, Canada
🇩🇪
Klinikum der Goethe-Universität, Zentrum für Dermatologie und Venerologie, Frankfurt, Germany

and more 4 locations

Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis

Phase 3

Completed

Conditions: Psoriasis of Scalp

First Posted Date: 2005-09-22

Last Posted Date: 2025-02-24

Lead Sponsor: LEO Pharma

Target Recruit Count: 1485

Registration Number: NCT00216827

Locations: 🇪🇸
Hospital Virgen de la Macarena, Servicio de Dermatología, Sevilla, Spain
🇬🇧
Western Infirmary, Dermatology Department, Glasgow, United Kingdom
🇸🇪
Akademiska Sjukhuset, Hudkliniken, Uppsala, Sweden

and more 5 locations

Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis

Phase 4

Completed

Conditions: Dermatitis, Atopic

Interventions: Drug: Methylprednisolone Aceponate (Advantan, BAY86-4862)
Drug: Placebo

First Posted Date: 2005-09-16

Last Posted Date: 2023-06-09

Lead Sponsor: LEO Pharma

Target Recruit Count: 250

Registration Number: NCT00185510

Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

Not Applicable

Terminated

Conditions: Liver Neoplasms

First Posted Date: 2003-01-14

Last Posted Date: 2025-02-25

Lead Sponsor: LEO Pharma

Target Recruit Count: 700

Registration Number: NCT00051532

Locations: 🇨🇦
E.g. University Health Network Toronto General Hospital (numerous facilities are recruiting in Canada), Toronto, Alberta, Canada
🇫🇷
E.g. Notre-Dame de Bon Secours, Service d´Hepato-Gastro-Enterologie (numerous facilities are recruiting in France), Metz, France
🇮🇹
E.g. Osp. Maggiore, Policlinico di Milano (numerous facilities are recruiting in Italy), Milano, Italy

and more 2 locations

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

Phase 3

Terminated

Conditions: Liver Neoplasms

First Posted Date: 2003-01-14

Last Posted Date: 2025-02-25

Lead Sponsor: LEO Pharma

Target Recruit Count: 608

Registration Number: NCT00051545

Locations: 🇫🇷
E.g., Hopital Notre-Dame de Bon Secour, Service de Hepato-gastro-enterologie (numerous facilities are recruiting in France), Metz, France
🇨🇦
E.g., University Health Network Toronto General Hospital (numerous facilities in Canada are recruiting), Toronto, Ontario, Canada
🇪🇸
E.g. Hospital Clinic Provincial de Barcelona (numerous facilities are recruiting in Spain), Barcelona, Spain

and more 2 locations

Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne

Phase 3

Completed

Conditions: Acne Vulgaris

Interventions: Drug: Vehicle gel (SH H 655 PBA)
Drug: Azelaic Acid Gel 15% (Finacea, BAY39-6251)

First Posted Date: 2002-02-22

Last Posted Date: 2023-06-09

Lead Sponsor: LEO Pharma

Target Recruit Count: 879

Registration Number: NCT00031096

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy